I
Immunovant, Inc. (IMVT)
NMS – Real vaqt narxi. Valyuta: USD
41.88
+0.95 (2.32%)
Bozor ochiq: Aug 12, 2026, 2:14 PM EDT
40.93
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:40 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
41.88
+0.95 (2.32%)
Bozor ochiq: Aug 12, 2026, 2:14 PM EDT
40.93
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:40 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Naqd pul zahiralari $797.8M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $851.2M jami joriy majburiyatlardan $117.1M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 7.27 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 7.27 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | -1M | -231K | -377K | -409K | -394K |
| Operatsion daromad | -208M | -270M | -438M | -533M | -566M |
| Sof foyda | -211M | -259M | -414M | -506M | -538M |
| EBITDA | -207M | -270M | -438M | -532M | -566M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 0.18 | 1.5 |
| Keyingi chorak | N/A | -17.27 | 1.0 |
| Joriy yil | N/A | -4.06 | 1.0 |
| Keyingi yil | N/A | 1.3 | 2.0 |
| O‘rtacha ball | 1.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -3.62 | 6.44 | -2.96 | 4.3 |
| Yil/Yil | 999 | -27.03 | 3.8 | 14.23 | 5.8 |
| 3 yil o‘rtacha | 999 | -34.87 | -18.85 | -32.51 | 3.3 |
| 5 yil o‘rtacha | 999 | -37.01 | -18.66 | -40.38 | 3.3 |
| O‘rtacha ball | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |